Food and Drug Administration FDA approves first oral GLP-1 treatment for type 2 diabetes
Among these, DFO has shown efficacy in reducing free iron levels in brain tissue
However, manufacturer discount programs, pharmacy coupons, and insurance negotiated rates can significantly reduce these costs
Use of bone graft substitutes in the management of tibial plateau fractures
In addition to helping regulate blood sugar, GLP-1 also stimulates insulin release after meals, slows stomach emptying, and reduces appetite
A 2026 review found that reports of hair loss have been seen across multiple studies and databases, with the strongest evidence currently linked to semaglutide (Wegovy) and tirzepatide (Mounjaro)